VIR
Vir Biotechnology Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||
| Capital Expenditures | 4.8M | 7.3M | 21.6M | 68.0M | 21.8M | 6.5M | 8.9M | 8.2M | 2.7M |
| Acquisitions | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||
| Free Cash Flow | -396.6M | -453.7M | -800.4M | 1.60B | -69.4M | -197.5M | -138.6M | -102.3M | -69.1M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — |